In November 2010, Bioseek Inc was acquired by Asterand and then in November 2012, was sold to DiscoverX Corporation and now operate as a wholly owned subsiduary. Focused on applying human primary cell assays and predictive disease models to the discovery and development of human therapeutics and safer chemicals, BioSeek is a human systems biology drug discovery company harnessing the bioinformatics content and processing power of living human cell systems to decipher rapidly the functions of genes, proteins and drugs for more efficient and predictive pharmaceutical discovery. The firm's proprietary technologies are being applied for the identification, validation and commercialization of novel and improved human therapeutics. The BioSeek platform of human primary cell culture-based technologies utilize an innovative complex systems biology approach for earlier and more accurate selection of targets and compounds at all stages of preclinical and clinical development. With these, the company expects to dramatically reduce the time and cost of preclinical and clinical drug development, initially in the areas of inflammation, cardiovascular disease and oncology.
